Vortrag

KP 1339 (BOLD-100), a first-in-class anticancer drug targeting metabolism of cancer

KP 1339 (BOLD-100), a first-in-class anticancer drug targeting metabolism of cancer

Veranstaltungen

05.07.24

14:00 – 15:15

Jena

Prof. Dr. Bernhard Keppler

Universität Wien

Vortrag im Kolloquium des GDCh-Ortsverbands Jena zum Abschied von Prof. Dr. Wolfgang Weigand

Kontaktperson

Prof.Dr. Martin Oschatz

Prof.Dr. Martin Oschatz


Zu Ihrem Kalender hinzufügen

KP 1339 (BOLD-100), a first-in-class anticancer drug targeting metabolism of cancer
KP 1339 (BOLD-100), a first-in-class anticancer drug targeting metabolism of cancer
KP 1339 (BOLD-100), a first-in-class anticancer drug targeting metabolism of cancer
KP 1339 (BOLD-100), a first-in-class anticancer drug targeting metabolism of cancer
In andere Kalender herunterladen

Veranstaltungsdetails

05.07.24

14:00 – 15:15

Jena

Prof. Dr. Bernhard Keppler

Universität Wien


Kontaktperson

Prof.Dr. Martin Oschatz

Prof.Dr. Martin Oschatz


Zu Ihrem Kalender hinzufügen

KP 1339 (BOLD-100), a first-in-class anticancer drug targeting metabolism of cancer
KP 1339 (BOLD-100), a first-in-class anticancer drug targeting metabolism of cancer
KP 1339 (BOLD-100), a first-in-class anticancer drug targeting metabolism of cancer
KP 1339 (BOLD-100), a first-in-class anticancer drug targeting metabolism of cancer
In andere Kalender herunterladen